{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:29:54Z","timestamp":1771615794876,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejso.2013.08.013","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T00:45:22Z","timestamp":1379033122000},"page":"970-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"P.","family":"Cascales Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascual","family":"Parrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2013.08.013_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1245\/ASO.2004.07.002","article-title":"Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei","volume":"11","author":"Deraco","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.10255","article-title":"Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion","volume":"83","author":"Deraco","year":"2003","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2013.08.013_bib3","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2004.05.044","article-title":"Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer","volume":"94","author":"Ryu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib5","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib6","doi-asserted-by":"crossref","unstructured":"www.clinicaltrials.gov. Last consult: 1-Dec-2012.","DOI":"10.1145\/2073242.2073247"},{"key":"10.1016\/j.ejso.2013.08.013_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2013.08.013_bib8","unstructured":"National Cancer Institute, Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0 (CTCAE). Available at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. [accessed June 10, 2013]."},{"key":"10.1016\/j.ejso.2013.08.013_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jso.21448","article-title":"Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer","volume":"101","author":"Kim","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejso.2011.03.134","article-title":"Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer","volume":"37","author":"Cascales Campos","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1055\/s-2003-44484","article-title":"Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion (CIIPHCP)","volume":"125","author":"Chatzigeorgiou","year":"2003","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.ejso.2013.08.013_bib12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00268-004-7461-x","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer","volume":"28","author":"Zanon","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2013.08.013_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7819-2-21","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer","volume":"2","author":"Piso","year":"2004","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","article-title":"Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan","volume":"32","author":"Raspagliesi","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00268-007-9146-8","article-title":"Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients","volume":"31","author":"Cotte","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2013.08.013_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with\u00a0paclitaxel-or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Di Giorgio","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.08.013_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7819-7-14","article-title":"Intra operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer","volume":"9","author":"Guardiola","year":"2009","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2009.03.004","article-title":"Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study","volume":"113","author":"Fagotti","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"15s","key":"10.1016\/j.ejso.2013.08.013_bib20","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1200\/jco.2009.27.15_suppl.5542","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: a multiinstitutional study of 246 patients","volume":"27","author":"Bereder","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejso.2009.03.004","article-title":"Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer \u2013 12-year single center experience","volume":"35","author":"Pavlov","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1245\/s10434-008-0299-y","article-title":"Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study","volume":"16","author":"Lim","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib23","article-title":"Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer","author":"Ceelen","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib24","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1684\/bdc.2010.1063","article-title":"Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer","volume":"97","author":"Carrabin","year":"2010","journal-title":"Bull Cancer"},{"key":"10.1016\/j.ejso.2013.08.013_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","article-title":"Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer","volume":"102","author":"Roviello","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejso.2010.04.005","article-title":"Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study","volume":"36","author":"Pomel","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.21732","article-title":"Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: a pilot study of 31 patients","volume":"103","author":"Frenel","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","author":"Fagotti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","article-title":"Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer","volume":"94","author":"Rufian","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12094-009-0438-3","article-title":"The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer","volume":"11","author":"Mu\u00f1oz-Casares","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/030089160108700302","article-title":"Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study","volume":"87","author":"Deraco","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.ejso.2013.08.013_bib33","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy\u2013 a journey to becoming a Nationally Funded Peritonectomy Center","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/cncr.21708","article-title":"Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique","volume":"106","author":"Kusamura","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.08.013_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/ASO.2003.01.018","article-title":"Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures","volume":"10","author":"Glehen","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","article-title":"Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2014a prospective study of 70 consecutive cases","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib38","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1245\/s10434-007-9348-1","article-title":"Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejso.2005.08.009","article-title":"Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei\u2014a report of 103 procedures","volume":"32","author":"Smeenk","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.20013","article-title":"Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"85","author":"Verwaal","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib42","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","article-title":"Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy","volume":"77","author":"Jacquet","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.08.013_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.20253","article-title":"Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis","volume":"90","author":"Elias","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib44","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bjs.6235","article-title":"Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"95","author":"Honore","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2013.08.013_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-4804(91)90014-D","article-title":"Effects of intraperitoneal chemotherapy on anastomotic healing in rats","volume":"50","author":"Fumagalli","year":"1991","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejso.2013.08.013_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jso.20161","article-title":"Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study","volume":"89","author":"Makrin","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2168.1998.02876.x","article-title":"Experimental study of the effect of preoperative 5-fluorouracil on the integrity of colonic anastomoses","volume":"85","author":"Kuzu","year":"1998","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2013.08.013_bib48","first-page":"1273","article-title":"The effect of intraperitoneal paclitaxel administration on colonic anastomosis","volume":"47","author":"Arikan","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejso.2013.08.013_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1055-3207(03)00026-7","article-title":"The etiology, clinical presentation, and management of pseudomyxoma peritonei","volume":"12","author":"Moran","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejso.2013.08.013_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2008.04.002","article-title":"Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy","volume":"35","author":"Hansson","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.08.013_bib51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00384-009-0660-z","article-title":"The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases","volume":"24","author":"Chow","year":"2009","journal-title":"Int J Colorectal Dis"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831300752X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831300752X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T15:02:54Z","timestamp":1688482974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879831300752X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S074879831300752X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2013.08.013","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2013.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}